Bristol Myers Squibb

“AstraZeneca is in talks to combine with peer pharmaceutical company Bristol Myers Squibb in a deal that would create a company valued at around $400 billion.”

“Ratio Therapeutics...raised a $70 million Series C from investors including Duquesne Family Office, Bristol Myers Squibb and Catalio Capital Management.”

“AstraZeneca has had merger talks with Bristol-Myers Squibb... A tie-up would create the world's fourth most valuable drugmaker, with around $400 billion in combined market cap.”